Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Cost of Revenue of $12.11 million for Q2 2026, up 94.2% from $6.24 million a year earlier and up 28.9% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tarsus Pharmaceuticals' Cost of Revenue came in at $40.75 million, up 107.7% year-over-year; for FY2025, it was $30.68 million, up 139.2% from FY2024.

  • Cost of Revenue has increased for three consecutive years, with a four-year compound annual growth rate of 96.1% (FY2021 to FY2025).
  • By year, Cost of Revenue came in at $12.83 million in FY2024 (+705.1%), $1.59 million in FY2023 (+66.8%), $955,000 in FY2022 (-54.0%) and $2.08 million in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2021.
  • Year over year, Cost of Revenue has now increased in each of the last eight quarters, with growth averaging 230.0% over the last eight quarters.
  • The high point for year-over-year Cost of Revenue in five years was Q3 2024 (growth of 759.9%); the low point was Q1 2022 (a decline of 97.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $9.4 million (Q1 2026), $10.93 million (Q4 2025) and $8.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn 12.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.11 Mn
Mar 31, 2026 9.40 Mn
Dec 31, 2025 10.93 Mn
Sep 30, 2025 8.31 Mn
Jun 30, 2025 6.24 Mn
Mar 31, 2025 5.21 Mn
Dec 31, 2024 4.93 Mn
Sep 30, 2024 3.24 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 377,000.00
Dec 31, 2022 400,000.00
Jun 30, 2022 522,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 -24,000.00
Sep 30, 2021 65,000.00
Jun 30, 2021 737,000.00
Mar 31, 2021 1.30 Mn
API Access

Tarsus Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TARS&period=max&api_key=YOUR_API_KEY